Skip to main content
SpringerLink
Log in

Small increased risk of acute coronary events with dabigatran

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Uchino K, Hernandez AV.Dabigatran Association With Higher Risk of Acute Coronary Events. Archives of Internal Medicine: 9 Jan 2012. Available from: URL: http://dx.doi.org/10.1001/archinternmed.2011.1666

  2. Jacobs JM, Stessman J.Dabigatran: Do We Have Sufficient Data? Archives of Internal Medicine: [3 pages], 9 Jan 2012. Available from: URL: http://archinte.ama-assn.org/cgi/reprint/archinternmed.2011.1666

  3. Redberg RF.Important Data After Drug Approval. Archives of Internal Medicine: [1 page], 9 Jan 2012. Available from: URL: http://archinte.ama-assn.org/cgi/reprint/archinternmed.2011.1666

  4. Hohnloser SH, Oldgren J, Yang S, Wallentin L, Ezekowitz M, Reilly P, Eikelboom J, Brueckmann M, Yusuf S, Connolly SJ.Myocardial Ischemic Events in Patients with Atrial Fibrillation Treated with Dabigatran or Warfarin in the RE-LY Trial. Circulation: [22 pages], 3 Jan 2012. Available from: URL: http://circ.ahajournals.org/content/early/2012/01/03/CIRCULATIONAHA.111.055970.full.pdf

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Small increased risk of acute coronary events with dabigatran. React. Wkly. 1385, 2 (2012). https://doi.org/10.2165/00128415-201213850-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201213850-00003

Keywords

Search

Navigation